Minim Launches Live Shopping Experience With HSN

Broadcast Shopping Segment Showcases Home Network Security Upgrades With Motorola WiFi 6 Mesh Portfolio MANCHESTER, NH, Dec. 22, 2022 (GLOBE NEWSWIRE) — ia NewMediaWire – Minim, Inc.,

Broadcast Shopping Segment Showcases Home Network Security Upgrades With Motorola WiFi 6 Mesh Portfolio

MANCHESTER, NH, Dec. 22, 2022 (GLOBE NEWSWIRE) — ia NewMediaWire – Minim, Inc., (NASDAQ:MINM), the creator of intelligent networking products under the Motorola brand, today announces its debut into live shopping with HSN, a leader in live stream shopping and on-air storytelling. The company’s first live shopping event will offer HSN viewers an engaging platform to purchase products from Motorola’s home networking portfolio. 

Hosted across HSN’s streaming platforms, Minim’s premiere segment will show viewers how to simplify and secure their home networks using the Motorola Q11 WiFi 6 Mesh Router System and motosync mobile app. HSN Guest Host and Lifestyle Expert Julie Truster will lead the segment, offering an exclusive limited-time deal on Motorola’s well-reviewed WiFi 6 mesh system. The pilot will debut following the Christmas holiday on Monday, December 26th. 

“The company’s recent expansions with leading e-commerce companies have revealed how consumers are embracing our products,” said Cristina Martinho, Vice President of Performance Marketing at Minim. “HSN’s engaging platform is a great way for Minim to tell their brand story and forge deeper connections with our audience.” 

The launch of the Motorola Q11 on HSN’s platform marks Minim’s first venture into live shopping entertainment. Following the broadcast, all content will be available on a dedicated product page currently live on HSN’s website. 

For more information about the entire portfolio of Motorola home network devices, please visit www.MotorolaNetwork.com.

Total
0
Shares
Related Posts
Read More

Gilead’s Kites Announced Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment With Yescarta CAR T-cell Therapy for Patients With Relapsed or Refractory Large B-cell Lymphoma at ASH 2022

Kite, a Gilead Company (Nasdaq: GILD), today announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta® (axicabtagene ciloleucel), the largest and longest follow-up of a CAR T-cell therapy versus standard of care (SOC) in patients with relapsed or refractory large B-cell lymphoma (r/r LBCL).

GILD